scholarly journals One-Year Health Care Costs Associated With Delirium in the Elderly Population

2008 ◽  
Vol 168 (1) ◽  
pp. 27 ◽  
Author(s):  
Douglas L. Leslie
2006 ◽  
Vol 9 (6) ◽  
pp. A255
Author(s):  
S Heinrich ◽  
M Luppa ◽  
MC Angermeyer ◽  
SG Riedel-Heller ◽  
HH Koenig

2013 ◽  
Vol 110 (12) ◽  
pp. 1288-1297 ◽  
Author(s):  
Patrick Lefebvre ◽  
Edith A. Nutescu ◽  
Mei Duh ◽  
Joyce LaMori ◽  
Brahim K. Bookhart ◽  
...  

SummaryIt was the objective of this study to quantify the risk of complications and the incremental health care costs associated with recurrent VTE events. Health care insurance claims from the Ingenix IMPACT database from 01/2004−09/2008 were analysed. Subjects aged ≥18 years on the date of first recurrent VTE diagnosis with ≥12 months of baseline observation prior to the index recurrent VTE were matched 1:1 with no-recurrent VTE patients based on propensity scores. The risk of developing post-thrombotic syndrome (PTS) and other disease-related diagnoses (thrombocytopenia, superficial venous thrombosis, venous ulcer, pulmonary hypertension, stasis dermatitis, and venous insufficiency) was compared between the recurrent and no-recurrent VTE groups for up to one year. All-cause and disease-related costs per patient per year (PPPY) were calculated. The recurrent VTE and no-recurrent VTE cohorts (8,001 subjects in each group) were matched with respect to age, gender, and comorbidities. The risk ratios (RRs) indicated that the risk of developing post-event complications was significantly higher for the recurrent VTE group compared to the no-recurrent VTE group (RR [95% CI]: PTS: 2.7 [2.4 − 2.9], p-value <0.01). Patients with recurrent VTE had significantly higher average PPPY all-cause costs compared to no-recurrent VTE patients ($86,744 versus $37,525, cost difference: $49,219 [€33,617]; 95% CI= 46,253−51,989). Corresponding disease-related health care costs PPPY were also significantly higher for the recurrent VTE group ($11,120 vs $1,262, cost difference: $9,858 [€6,733]; 95% CI= $9,081-$10,476). In conclusion, in this large matched-cohort study, recurrent VTE patients had significantly higher risk of complications and health care costs compared to no-recurrent VTE patients.Note: Parts of this manuscript were presented at the American College of Clinical Pharmacy (ACCP) Annual Meeting 2012, October 21–24, Hollywood, Florida and at the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) 18th Annual International Meeting 2013, May 18–22, New Orleans, LA, USA.


2012 ◽  
Vol 15 (7) ◽  
pp. A607
Author(s):  
R. Sruamsiri ◽  
N. Jeanpeerapong ◽  
K. Jampachaisri ◽  
N. Chaiyakunapruk

2019 ◽  
Vol 8 (1) ◽  
pp. 27-35
Author(s):  
Burkay Yakar ◽  
Mehtap Gömleksiz ◽  
Edibe Pirinççi

Aim: It is known that increasing health literacy can increase people's quality of life, enable them to benefit from health services more effectively and contribute to reducing health care costs. Inadequate health literacy has been reported to lead to insufficient health information, high risk of ill health, low level of understanding of treatment methods and increase in health care costs. Today, increasing number of chronic diseases, increasing the elderly population and increasing the budget allocated to health services have also increased the importance of health literacy levels. In this context, it is aimed to investigate health literacy levels and factors affecting our country. Methods: Our cross-sectional study was conducted in voluntary patients who applied to the family medicine outpatient clinic of a university. In our study, sociodemographic questionnaire form and Turkish Health Literacy Scale were used for data collection. Chi-square test was used for statistical analysis and p Results: 225 volunteers were included in our study. 62,1% of them were women. The mean score of the health literacy scale was 25.5±10.2. 50.6% of the participants were inadequate, and 25.1% of them had problematic health literacy level. The level of health literacy was found to be significantly lower in women, who had low education level, who were married and had children and who had vision problems. Conclusion: The data obtained from our study showed that our health literacy levels are low. We need to develop policies that increase our levels


2020 ◽  
Vol 30 (4) ◽  
pp. 628-632
Author(s):  
Sören Dallmeyer ◽  
Pamela Wicker ◽  
Christoph Breuer

Abstract Background Increasing health care costs represent an economic burden placed on individuals across many European countries. Against this backdrop, the aim of this study was to examine the relationship between participation in physical activity and out-of-pocket health care costs in Europe. Methods Individual data from the cross-national Survey of Health, Ageing and Retirement (n = 94 267) including 16 European countries were utilized. Two-part models were estimated to investigate how different levels of participation frequency in physical activity are related to out-of-pocket costs (OOPC) for people aged 50 years and older. Results Only participation in physical activity more than once a week significantly decreases the probability of incurring any OOPC. However, all frequencies of physical activity significantly reduce the level of costs, with the highest savings being generated by participation once a week. The results reveal higher savings for men compared to women. Conclusion Physical activity can be a useful policy instrument to reduce the economic burden of out-of-pocket health care costs for an aging population in Europe. Public officials should primarily promote physical activity interventions targeting older people who are not active at all.


2005 ◽  
Vol 6 (4) ◽  
pp. 301-304
Author(s):  
Giorgio D’Allio ◽  
Fernando Rutto ◽  
Michela Coppi ◽  
Luca Guidi

The present study was designed to evaluate the level of dependence from Mental Health Care Department, in Casale Monferrato, of three groups of psychotic patients treated with olanzapine (31), risperidone (30) or typical neuroleptics (31). The observation was retrospective, lasting one year (2003-2004), and collected data relative to health care resources as specialist visits, home interventions operated by nurses or physicians, drug administration, rehabilitation, psychotherapy, hospitalizations. The data collected allowed to evidentiate substantial differences among olanzapine and risperidone treated patients, usually younger, versus typical treated patients, usually older and more chronic. In general, atypical treated patients, evidentiate a reduction of home nurse intervention in respect to typical treated patients while olanzapine shows a trend in hospitalization and specialist visits reduction versus risperidone. Total health care costs are not significantly different among the three groups but evidentiate interventions more oriented to rehabilitation in the group treated with olanzapine while risperidone treated patients needed a major number of hospitalizations. Typical treated patients requested, instead, an high number of home intervention due to their chronic conditions and cognitive imparement.


Sign in / Sign up

Export Citation Format

Share Document